Streptozotocin-induced mechanical hypernociception is not dependent on hyperglycemia

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 2, 2009, Pages 197-206

  Cunha, Joice M ^a   Funez, M I ^a   Cunha, F Q ^a   Parada, C A ^b   Ferreira, S H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Hyperglycemia; Insulin and glucose tolerance test; Mechanical hyperalgesia; Streptozotocin

Indexed keywords

DEXAMETHASONE; GLUCOSE; ISOPHANE INSULIN; MORPHINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERALGESIA; HYPERGLYCEMIA; MALE; NOCICEPTION; NONHUMAN; PAW EDEMA; RAT; SENSORY NERVE CELL; STREPTOZOCIN DIABETES; WEIGHT GAIN;

RATTUS; RATTUS NORVEGICUS;

EID: 65549105009     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000200008     Document Type: Article

References (39)

1. Veglio M, Sivieri R. Prevalence of neuropathy in IDDM patients in Piemonte, Italy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes, Piemonte Affiliate. Diabetes Care 1993; 16: 456-461.
2. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164.
3. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, et al. Nerve glucose, fructose, sorbitol, myoinositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988; 319: 542-548.
4. Calcutt NA. Future treatments for diabetic neuropathy: clues from experimental neuropathy. Curr Diab Rep 2002; 2: 482-488.
5. Forman LJ, Estilow S, Lewis M, Vasilenko P. Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes 1986; 35: 1309-1313.
6. Lee JH, McCarty R. Glycemic control of pain threshold in diabetic and control rats. Physiol Behav 1990; 47: 225-230.
7. Lee JH, McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain 1992; 50: 231-236.
8. Courteix C, Eschalier A, Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 1993; 53: 81-88.
9. Malcangio M, Tomlinson DR. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 1998; 76: 151-157.
10. Wuarin-Bierman L, Zahnd GR, Kaufmann F, Burcklen L, Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia 1987; 30: 653-658.
11. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 1994; 57: 153-160.
12. Courteix C, Bardin M, Massol J, Fialip J, Lavarenne J, Eschalier A. Daily insulin treatment relieves long-term hyperalgesia in streptozotocin diabetic rats. Neuroreport 1996; 7: 1922-1924.
13. Calcutt NA, Chaplan SR. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 1997; 122: 1478-1482.
14. Sasaki T, Yasuda H, Maeda K, Kikkawa R. Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport 1998; 9: 243-247.
15. Khan GM, Chen SR, Pan HL. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 2002; 114: 291-299.
16. Malmberg AB, Yaksh TL, Calcutt NA. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci Lett 1993; 161: 45-48.
17. Calcutt NA, Malmberg AB, Yamamoto T, Yaksh TL. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain 1994; 58: 413-420.
18. Calcutt NA, Li L, Yaksh TL, Malmberg AB. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur J Pharmacol 1995; 285: 189-197.
19. Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 1996; 68: 293-299.
20. Aley KO, Levine JD. Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain 2001; 2: 146-150.
21. Dobretsov M, Hastings SL, Stimers JR, Zhang JM. Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J Neurosci Methods 2001; 110: 9-15.
22. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res 2003; 960: 174-183.
23. Gupta M, Singh J, Sood S, Arora B. Mechanism of antinociceptive effect of nimodipine in experimental diabetic neuropathic pain. Methods Find Exp Clin Pharmacol 2003; 25: 49-52.
24. Romanovsky D, Hastings SL, Stimers JR, Dobretsov M. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes. J Peripher Nerv Syst 2004; 9: 62-69.
25. Ferreira SH, Lorenzetti BB, Correa FM. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
26. Kwon NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J 1994; 8: 529-533.
27. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 537-546.
28. Yamamoto H, Uchigata Y, Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981; 294: 284-286.
29. Fox A, Eastwood C, Gentry C, Manning D, Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 1999; 81: 307-316.
30. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001; 24: 1229-1231.
31. Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S, et al. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 2002; 18: 473-483.
32. Taddese A, Nah SY, McCleskey EW. Selective opioid inhibition of small nociceptive neurons. Science 1995; 270: 1366-1369.
33. Silbert SC, Beacham DW, McCleskey EW. Quantitative single-cell differences in mu-opioid receptor mRNA distinguish myelinated and unmyelinated nociceptors. J Neurosci 2003; 23: 34-42.
34. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
35. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79: 376-384.
36. Kovalovsky D, Refojo D, Holsboer F, Arzt E. Molecular mechanisms and Th1/ Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol 2000; 109: 23-29.
37. Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 2006; 112: 116-138.
38. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokinemediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000; 130: 1418-1424.
39. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003; 23: 1026-1040.